ArticleProstate cancer and prostatic diseases2023

Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?

Zachary Klaassen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.